drugset / Trial / NCT01333163

GLP-1: Acute Effects on Kidney Function in Healthy Men

NCT01333163

Completed 12 enrolled Jeppe Skov Novo Nordisk A/S · collab
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.

Timeline

Start
2011-05
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator GLP-1 (7-36) amide Unknown 1.5 unknown Intravenous

Indications

No indication recorded.